Advanced Solid Tumors
Showing NaN - NaN of 80
Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)
Not yet recruiting
- Advanced Solid Tumors
- LCB84
- Anti-PD-1 monoclonal antibody
-
Los Angeles, California
- +6 more
Jul 4, 2023
Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)
Not yet recruiting
- Advanced Solid Tumors
-
Hackensack, New Jersey
- +10 more
Jun 6, 2023
Advanced Solid Tumors, NSCLC Trial in Israel, United States (BAY2862789)
Not yet recruiting
- Advanced Solid Tumors
- Non-small Cell Lung Cancer
-
Detroit, Michigan
- +5 more
May 5, 2023
Advanced Solid Tumors Trial in Worldwide (AMG 650)
Active, not recruiting
- Advanced Solid Tumors
- AMG 650
-
Los Angeles, California
- +21 more
Jan 26, 2023
Advanced Solid Tumors Trial in Houston (PUR001)
Recruiting
- Advanced Solid Tumors
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jan 18, 2023
Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)
Active, not recruiting
- Advanced Solid Tumors
- Elimusertib (BAY1895344)
- Pembrolizumab
-
Palo Alto, California
- +15 more
Jan 6, 2023
Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation Trial in Worldwide (Sotorasib, AMG 404, trametinib)
Recruiting
- Advanced Solid Tumors
- Kirsten Rat Sarcoma (KRAS) pG12C Mutation
- Sotorasib
- +15 more
-
Tucson, Arizona
- +83 more
Dec 28, 2022
NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)
Recruiting
- Non-small Cell Lung Cancer (NSCLC)
- +3 more
-
Boston, Massachusetts
- +9 more
Dec 22, 2022
Advanced Solid Tumors, Glioblastoma, Soft Tissue Sarcoma (Excluding GIST) Trial in Boston, Madrid, Sevilla (Lurbinectedin,
Recruiting
- Advanced Solid Tumors
- +11 more
-
Boston, Massachusetts
- +4 more
Dec 12, 2022
Advanced Solid Tumors Trial in Worldwide (AMG 256)
Active, not recruiting
- Advanced Solid Tumors
- AMG 256
-
Duarte, California
- +10 more
Dec 1, 2022
Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)
Recruiting
- Lymphoma, Non-Hodgkin
- +2 more
- Crizotinib
- +17 more
-
Birmingham, Alabama
- +125 more
Nov 21, 2022
Advanced Solid Tumors, HER2-positive Breast Cancer Trial in United States (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041
Recruiting
- Advanced Solid Tumors
- HER2-positive Breast Cancer
- ZN-A-1041 50mg BID
- +12 more
-
Tucson, Arizona
- +6 more
Nov 16, 2022
Advanced Solid Tumors Trial in Worldwide (AMG 994, AMG 404)
Active, not recruiting
- Advanced Solid Tumors
- AMG 994
- AMG 404
-
Duarte, California
- +16 more
Nov 16, 2022
Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)
Recruiting
- Advanced Solid Tumors
-
New Haven, Connecticut
- +19 more
Nov 10, 2022
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)
Completed
- Advanced Malignancy
- +5 more
- AMG 337
-
Los Angeles, California
- +7 more
Nov 3, 2022
Advanced Solid Tumors Trial in United States (FF-10850 Topotecan Liposome Injection)
Recruiting
- Advanced Solid Tumors
- FF-10850 Topotecan Liposome Injection
-
Scottsdale, Arizona
- +5 more
Oct 19, 2022
Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))
Active, not recruiting
- Advanced Solid Tumors
- DS-8201a (DP1)
- +2 more
-
San Diego, California
- +13 more
Oct 4, 2022
Advanced Solid Tumors, Squamous Cell Carcinoma of the Head and Neck (SCCHN), Gastrointestinal (GI) Malignancies Trial in
Recruiting
- Advanced Solid Tumors
- +2 more
- INCA00186
- +2 more
-
Los Angeles, California
- +31 more
Jul 20, 2022